Pneumococcal Vaccination is Key to Protecting Cochlear Implant PatientsCochlear implants bring sound to thousands of people with hearing loss worldwide. People with cochlear implants are at increased risk for pneumococcal meningitis.
The American Academy of Otolaryngology—Head and Neck Surgery considers unilateral and bilateral cochlear implantation as appropriate treatment for adults and children with severe to profound hearing loss.
The American Academy of Otolaryngology-Head and Neck Surgery considers active middle ear implants as appropriate treatment for adults with moderate to severe hearing loss when performed by a qualified otolaryngologist-head and neck surgeon.
The American Academy of Otolaryngology—Head and Neck Surgery recognizes that after general surgical training an otolaryngology resident spends four years being educated and trained in the head and neck region.
The American Academy of Otolaryngology-Head and Neck Surgery endorses the concept of the Hearing in Noise Test (HINT) and Consonant-Noise-Consonant (CNC) Test as minimal research reporting requirements for results of cochlear implantation in adults.